Ruxolitinib for tocilizumab-refractory severe COVID-19 infection.

Saved in:
Bibliographic Details
Title: Ruxolitinib for tocilizumab-refractory severe COVID-19 infection.
Authors: Innes AJ; Centre for Haematology, Department of Immunology & Inflammation, Imperial College London, London, UK.; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK., Cook LB; Centre for Haematology, Department of Immunology & Inflammation, Imperial College London, London, UK.; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK., Marks S; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK., Bataillard E; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK., Crossette-Thambiah C; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK., Sivasubramaniam G; Department of Respiratory Medicine, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK., Apperley J; Centre for Haematology, Department of Immunology & Inflammation, Imperial College London, London, UK.; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK., Milojkovic D; Centre for Haematology, Department of Immunology & Inflammation, Imperial College London, London, UK.; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
Source: British journal of haematology [Br J Haematol] 2020 Aug; Vol. 190 (4), pp. e198-e200. Date of Electronic Publication: 2020 Jul 26.
Publication Type: Clinical Trial; Letter
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2141
DOI:10.1111/bjh.16979